Certara Overview

  • Status
  • Public
  • Employees
  • 899
Employees
  • Stock Symbol
  • CERT
Stock Symbol
  • Investments
  • 13
  • Share Price
  • $36.80
  • (As of Monday Closing)

Certara General Information

Description

Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides proven modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines.

Contact Information

Website
www.certara.com
Formerly Known As
Tripos
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Decision/Risk Analysis
Stock Exchange
NAS
Primary Office
  • 100 Overlook Center
  • Suite 101
  • Princeton, NJ 08540
  • United States
+1 (415) 000-0000

Certara Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Certara Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$36.80 $37.33 $29.70 - $41.79 $5.63B 153M 1.52M

Certara Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2020 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
Revenue 233,000 233,000 208,511 163,719
EBITDA 60,413 32,252
Net Income (8,926) (33,258)
Total Assets 1,037,069 1,051,493
Total Debt 401,379 408,280
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Certara Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Certara‘s full profile, request access.

Request a free trial

Certara Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug d
Other Healthcare Technology Systems
Princeton, NJ
899 As of 2020
00000
0.000 0000-00-00
00000000 00000

00000000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptat
00000 0000000000 0000000000 0000000
Oxford, United Kingdom
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

0000 000

psum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolo
0000000000000
Seattle, WA
00 As of 0000
0000
000 0000-00-00
000000&0 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Certara Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exscientia Venture Capital-Backed Oxford, United Kingdom 00 00000 00000000000 00000
0000 0000000000000 Formerly VC-backed Seattle, WA 00 0000 000000&0 0000
00000000 000000000 Private Equity-Backed Montreal, Canada 00 00000000. 00
00000000 0000 0000 Private Equity-Backed Milford, MA 000 000000000000
000000 Venture Capital-Backed Palo Alto, CA 00 000.00 0000000000 0 000.00
You’re viewing 5 of 8 competitors. Get the full list »

Certara Executive Team (22)

Name Title Board Seat Contact Info
William Feehery Chief Executive Officer & Board Member
Andrew Schemick Chief Financial Officer
Jieun Choe Chief Marketing Officer, Marketing & Chief Strategy Officer, Strategy
Roman Casciano Senior Vice President & General Manager
Jodi Dickinson Chief Human Resources Officer and Senior Vice President of Human Resources
You’re viewing 5 of 22 executive team members. Get the full list »

Certara Board Members (17)

Name Representing Role Since
0000 000 EQT Board Member 000 0000
00000 0000000 000 Certara Board Member 000 0000
00000 000000 Self Board Member 000 0000
00000000 00000 Certara Chairman & Board Member 000 0000
0000000 000000 Arsenal Capital Partners Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Certara Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Certara Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Certara‘s full profile, request access.

Request a free trial

Certara Investments (13)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 13-Sep-2018 0000000000 Business/Productivity Software 000000 00000000 00.0
000000000 00000 12-Apr-2018 0000000000 Consulting Services (B2B) 000000 00000000 00.0
00000000 01-Feb-2018 0000000000 Business/Productivity Software 00000 00000000
00 00000000 07-Sep-2016 0000000000 Drug Delivery
Xenologiq 01-Dec-2015 Buyout/LBO Consulting Services (B2B)
You’re viewing 5 of 13 investments. Get the full list »

Ready to get started?

Request a free trial

Certara Subsidiaries (3)

Company Name Industry Location Founded
BaseCase Business/Productivity Software Berlin, Germany 2007
000000000 00000 Consulting Services (B2B) London, United Kingdom 0000
000000000 Business/Productivity Software Mountain View, CA 0000
To view Certara’s complete subsidiaries history, request access »

Certara Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 30-Apr-2002 00000 00000 00 00.00 Completed
  • 2 buyers
0000000 01-May-2000 0000 00000 Completed
  • 3 buyers
Arena Pharmaceuticals 22-Feb-1999 Later Stage VC 0000 Completed
  • 5 buyers
To view Certara’s complete exits history, request access »